News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
September 3, 2025
·
3 min read
Press Releases
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
September 3, 2025
·
5 min read
Press Releases
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
August 29, 2025
·
3 min read
Press Releases
Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007
August 28, 2025
·
5 min read
Press Releases
Stereotaxis Reports 2025 Second Quarter Financial Results
August 8, 2025
·
9 min read
Press Releases
C2N Announces Major Global Expansion, Adds Six New International Partners
August 8, 2025
·
4 min read
Press Releases
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
July 29, 2025
·
4 min read
Press Releases
CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS
July 25, 2025
·
30 min read
Press Releases
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
July 25, 2025
·
4 min read
Press Releases
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
·
1 min read
Press Releases
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
July 18, 2025
·
4 min read
Press Releases
Geneoscopy to Participate in Upcoming Investor Conferences - July 17, 2025
July 18, 2025
·
1 min read
Press Releases
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
July 15, 2025
·
4 min read
Press Releases
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
July 2, 2025
·
4 min read
Press Releases
Stowers Institute Investigator Named 2025 Freeman Hrabowski Scholar by HHMI
June 30, 2025
·
3 min read
Press Releases
Acera Surgical Broadens Reach of Restrata® with New FDA Clearance for Soft Tissue Reinforcement
June 26, 2025
·
2 min read
Press Releases
Modeling Study Published in Clinical Gastroenterology and Hepatology Validates Geneoscopy’s ColoSense® Real-World Screening Impact
June 24, 2025
·
5 min read
Press Releases
Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery
June 10, 2025
·
4 min read
Press Releases
Geneoscopy’s RNA-Based ColoSense Test Included in Latest National Comprehensive Cancer Network (NCCN) Guidelines
June 3, 2025
·
4 min read
Press Releases
Former POINT Biopharma CEO, Joe McCann, Joins TAG1 Board of Directors to Advance Isotope Access in Radiopharmaceuticals
May 20, 2025
·
2 min read